Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Jun 4, 2011
The median survival rate for cancer patients who received targeted matched therapy improved by 4.4 months, a new study showed. Dr. Apostolia-Maria Tsimberidou discusses the results. For more, visit www.imngoncology.com.